Open AccessCRLX101, a Nanoparticle–Drug Conjugate Containing Camptothecin, Improves Rectal Cancer Chemoradiotherapy by Inhibiting DNA Repair and HIF1α
Author(s) -
Tian Xia,
Minh Tho Nguyen,
Henry P. Foote,
Joseph M. Caster,
Kyle C. Roche,
Christian Peters,
Pauline Wu,
Lata Jayaraman,
Edward G. Garmey,
Joel E. Tepper,
Scott Eliasof,
Andrew Z. Wang
Publication year - 2017
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/7dn3-jk30
Subject(s) - camptothecin , conjugate , colorectal cancer , drug , chemoradiotherapy , cancer research , medicine , cancer , oncology , chemistry , pharmacology , biochemistry , mathematical analysis , mathematics